Comprehensive Metabolic Panel Testing Market To Reach $22.07 Billion By 2030

April 2025 | Report Format: Electronic (PDF)

Comprehensive Metabolic Panel Testing Market Growth & Trends

The global comprehensive metabolic panel testing market is anticipated to reach USD 22.07 billion by 2030 and is expected to expand at a CAGR of 9.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of chronic conditions such as diabetes, kidney disorders, and cardiovascular ailments is the major factor contributing to the market’s growth.

Technological innovations are reshaping diagnostic capabilities, with automated platforms and point-of-care devices enhancing testing speed, accuracy, and accessibility. Advanced systems now integrate AI for data analysis, allowing precise interpretation of results and predictive insights.

Moreover, heightened awareness of preventive care is transforming healthcare consumption patterns. Public health campaigns and policy initiatives emphasize early intervention to curb long-term costs, prompting individuals to prioritize regular metabolic screenings. Insurers are increasingly covering these tests within preventive care packages, reinforcing their adoption.

key Request a free sample copy or view report summary: Comprehensive Metabolic Panel Testing Market Report

Comprehensive Metabolic Panel Testing Market Report Highlights

Glucose accounted for the largest revenue share of 11.0% in 2024, attributed to the increased emphasis on early detection and preventive healthcare, coupled with lifestyle-related factors such as sedentary habits and poor diets.
The K+ segment is expected to grow at the fastest CAGR of 10.0% over the forecast period, owing to rising cases of kidney diseases, cardiovascular disorders, and electrolyte imbalances requiring precise monitoring of K+ levels.
The kidney diseases dominated the global comprehensive metabolic panel testing market and accounted for the largest revenue share of 32.4% in 2024, primarily driven by increased incidence of hypertension, diabetes, and obesity, alongside environmental factors such as pollution and dietary salt overconsumption.
The diabetes segment is expected to grow at the fastest CAGR of 10.3% over the forecast period, due to technological advancements enabling precise, accessible testing and expanded health insurance coverage for preventive screenings
The laboratories segment held the dominant position in the market with the largest revenue share in 2024. The PoC segment is expected to grow at the fastest CAGR of 10.3% from 2025 to 2030.
North America dominated the global comprehensive metabolic panel testing market with the largest revenue share in 2024, primarily driven by the high prevalence of chronic diseases such as diabetes, kidney disorders, and cardiovascular conditions, necessitating routine metabolic monitoring.
Key companies operating in the global comprehensive metabolic panel testing market include Abbott, Quest Diagnostics, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories.

Comprehensive Metabolic Panel Testing Market Segmentation

Grand View Research has segmented the global comprehensive metabolic panel testing market on the basis of analytes, disease, end use, and region:

Comprehensive Metabolic Panel Testing Analytes Outlook (Revenue, USD Million, 2018 - 2030)

K+
Na+
Cl-
CO2
Glucose
BUN
Creatinine
Ca++
Albumin
Total protein
ALP
ALT
AST
Total bilirubin

Comprehensive Metabolic Panel Testing Disease Outlook (Revenue, USD Million, 2018 - 2030)

Kidney Disease
Liver Disease
Diabetes
Others

Comprehensive Metabolic Panel Testing End Use Outlook (Revenue, USD Million, 2018 - 2030)

Laboratory
- Emergency dept.
- Hospital wards
- Primary care
- Pharmacy
- Telemedicine
PoC
- Emergency dept.
- Hospital wards
- Primary care
- Pharmacy
- Telemedicine
PoC (Instruments)
- Piccolo Xpress
- Skyla-HB1
- DRI-CHEM NX500
- Others